In the 1940s, curare in its various forms was a regular part of many anaesthetics. Clearly anaesthetists could not continue to rely on a drug which required occasional trips up the Amazon into the South American jungle and it was desirable that a synthetic relaxant be found. At the end of the decade, two drugs became available almost simultaneously -decamethonium, a depolarizing relaxant and gallamine, a nondepolarizing relaxant developed by Professor Daniel Bovet. At this time Daniel Bovet was Chief of Chemistry at the Instituto Superiore di Sanitá in Rome, but much of his earlier work had been completed at the Pasteur Institute in Paris.
His work was prolific and centered on biological amines. By 1937, he and his colleagues had synthesised the first antihistamine and later research included sympatholytic compounds and curarelike substances. In 1946 he succeeded in isolating a substance, 8'-8"-diquinolyloxy-1,5-pentane di-iodoethylate, which had curarelike properties but was not extensively used in anaesthesia. Subsequent analysis led to the development of gallamine (Flaxedil) which showed reliable activity and an apparent paucity of undesirable side-effects. Gallamine, or tri-(b-diethylaminoethoxy)benzene triethiodide, acted the same way as curare, inhibiting the depolarizing action of acetylcholine at the neuromuscular junction. The dose ratio was 4 mg gallamine to 1 mg d-tubocurarine. Unlike d-tubocurarine, gallamine was shown to have a greater atropinelike blocking action on the vagus and an insignificant effect on ganglionic transmission. For his work on gallamine and other pharmacological agents, Bovet was awarded the Nobel Prize for Physiology or Medicine in 1957.
Gallamine was first used in anaesthesia in 1948 by Huguenard and Bouè in France. The following year it was introduced into the U.K. by Mushin and into Canada by Hudon and Jacques. It was supplied in glass ampoules, 80 mg in 2 ml or 120 mg in 3 ml, and anaesthetists soon found that it had many apparent advantages. Beryl Harrison reported: "It is miscible with sodium thiopentone, so that only one intravenous injection is required, relaxation of the jaw is excellent, permitting of an easy and leisurely intubation under direct vision … the patient is ready for operation in a very short period of time, a considerable advantage with a lengthy list."
Gallamine was also thought to cause some sparing of the respiratory muscles. Cyril Scurr reported in a review of muscle relaxants that this was probably overstated, but presumably conferred a margin of safety in unskilled hands. He also noted that tachycardia was universally present, but rarely above 100 per minute. "No harm seems to result from this effect, but one feels, at least, that it is a bad start and may imply a reduced circulatory reserve."
The compatibility of gallamine with thiopentone, with its apparent respiratory muscle-sparing effect, led to its use as an infusion in 1953. Evans and Gray at St Bartholomew's Hospital reported 120 anaesthetics for major abdominal surgery where the patients were anaesthetized with a thiopentone-gallamine infusion. This novel technique arose out of their use of thiopentone as an infusion for analgesia during spinal anaesthesia. The patients were premedicated, usually with pethidine and atropine or omnopon and scopolamine. Induction with 500 mg thiopentone and 80 mg gallamine was followed by intubation. A drip containing 1g of thiopentone and 240 mg of gallamine in 480 cc of normal saline was commenced at "60 drops per minute at first until abdominal relaxation is perfect… when the patient is stabilized the rate of drip is reduced to 32 per minute. We have found that adequate respiration can be maintained with full abdominal relaxation." These patients were not ventilated after the initial period of paralysis: "Nitrous oxide-oxygen in the ratio of 5 litres to 21/2 litres is then given. Often respiration is temporarily depressed after induction, and it should be aided until satisfactory tidal volume returns."
It was well known that curare was contraindicated in myasthenia gravis but it had been used as a diagnostic tool. John Dundee considered that the respiratory-sparing effect of gallamine would make it a safer drug for this test. He conducted a controlled experiment on a woman with suspected myasthenia. She was suffering from periodic loss of voice and difficulty lifting her head from the pillow, which had not improved after administration of neostigmine and atropine. "Complete ptosis, a choking sensation and troublesome salivation followed intravenous injection of 1 mg. of d-tubocurarine." The problem was reversed with neostigmine and atropine, the procedure being described by the patient as definitely unpleasant." A similar experiment with a small dose of gallamine produced only ptosis and loss of voice, which was preferred by the patient. Three patients with confirmed myasthenia gravis were then retested with gallamine and found it to be more pleasant than their original tests with curare.
Some anaesthetists noted that a small number of non-myasthenic patients were very sensitive to gallamine and H. A Condon reported a series of such patients at the Hammersmith Hospital, their patients being routinely given a 20 mg trial dose of relaxant prior to induction in order to determine whether sensitivity was present. Two patients were found to be extremely sensitive but it is unlikely that either appreciated the test dose to the same extent as the researchers: "... within 60 seconds the patient became alarmed and pointed repeatedly to his chest. Anaesthesia was at once induced with thiopentone 0.5 g." These findings led them to conclude "Although flaxedil is miscible with thiopentone, the administration of such a mixture is unwise since sensitivity cannot be excluded by means of a test dose ... our opinion on the need for a preliminary test dose is reaffirmed".
Gallamine was subsequently found to be excreted unchanged in the urine which led to prolonged action in patients with renal failure. This, and its vagolytic action, meant that it was eventually superseded by other agents, but nevertheless it was successfully and widely used for many decades.
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